Skip to content

Impact of thickening agent on the absorption pharmacokinetics of crushed paracetamol tablets in a healthy population.

Randomised single dose open label study to determine the bioavailability of paracetamol when mixed with different types of food after an oral administration of two tablets to healthy adults under fasting conditions

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000498796
Enrollment
20
Registered
2013-05-06
Start date
2013-05-03
Completion date
2014-01-16
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People having issues swallowing their medications may crush it and mix with food or drinks. In aged care homes and for dysphagic patients it is common to thicken water with commercial thickening agents to provide the correct viscosity to enable swallowing. In an in vitro study, we have found that drug dissolution was consistently reduced when the tablets were crushed and mixed with a commercially available thickened fluid consisting of xanthan gum and maltodextrin. It was observed that mixing crushed tablets with thickened fluid caused prolonged dissolution time compared to other mixers (water, jam, yogurt, honey and juice) and compared to dissolution of the whole tablet. Based on our in vitro data, we hypothesise that the rate of drug absorption will be significantly slowed, and the maximum drug concentration reached will be reduced when a drug is crushed and mixed with the thickened fluid in comparison to the whole tablet, crushed tablet delivered in water, and crushed tablet mixed with jam.

Interventions

This is a randomized study, on arrival at the venue participants (20 healthy volunteers) will receive a standard dose of 1 g paracetamol (two 500 mg tablets), and will receive one of the following treatments. Treatment 1: Tablets will be swallowed whole with 250 ml of water. Treatment 2: Tablets will be swallowed whole with 250 ml of water. Treatment 3: Tablets that have been crushed and mixed with 100 ml of water will be swallowed, followed by another 150 ml water to be used to rinse the mou

This is a randomized study, on arrival at the venue participants (20 healthy volunteers) will receive a standard dose of 1 g paracetamol (two 500 mg tablets), and will receive one of the following treatments. Treatment 1: Tablets will be swallowed whole with 250 ml of water. Treatment 2: Tablets will be swallowed whole with 250 ml of water. Treatment 3: Tablets that have been crushed and mixed with 100 ml of water will be swallowed, followed by another 150 ml water to be used to rinse the mouth during swallowing. Treatment 4: Tablets that have been crushed and mixed with a commercial thickened fluid (15 g EasyThick) will be swallowed, followed by 250 ml water to be used to rinse the mouth during swallowing. Treatment 5: Tablets that have been crushed and mixed with jam (15 g) will be swallowed, followed by 250 ml of water to be used to rinse the mouth during swallowing. Washout period : 7 days

Sponsors

A/Prof Kathryn Steadman
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Male or Female Age 18 to 65 years Participant has had previous exposure to paracetamol with no adverse events. Participants understand and voluntarily agree to participate in this study by providing written consent.

Exclusion criteria

Previous history of allergy or sensitivity to paracetamol Consumed paracetamol in the last 24 hours before the study People for whom paracetamol treatment is contraindicated or for whom paracetamol safety and disposition could be altered (e.g. hepatic dysfunction) Smokers Pregnancy Consumed food within 2 hour prior to the start of the study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026